Toxicity and outcomes associated with high-dose rate brachytherapy for medically inoperable endometrial cancer.

Purpose: To evaluate toxicity in inoperable endometrial cancer (EC) treated with definitive radiation therapy (RT).

Materials And Methods: Patients treated with definitive RT for EC were retrospectively reviewed. EQD2 values were calculated for bladder, rectum, and sigmoid.

Treatment of locally advanced cervical cancer in a patient with a bicornuate uterus with MRI-guided intracavitary/interstitial brachytherapy.

Purpose: Definitive treatment for locally advanced cervical cancer (LACC) includes external beam radiation therapy (EBRT) with concurrent cisplatin and brachytherapy. Image-guided intracavitary brachytherapy utilizes CT and/or MRI for target and organ at risk delineation and has been shown to improve local control rates and decrease toxicity. Hybrid intracavitary/interstitial applicators can be used to improve tumor coverage in certain cases.

Interatrial Bronchogenic Cyst Resection.

Interatrial bronchogenic cysts are rare entities, and the long-term clinical sequelae are unknown. This case report details the removal of a large (>4 cm) interatrial bronchogenic cyst that had been present for more than 10 years. Surgical resection remains the current standard of therapy when encountering an interatrial mass.

Postoperative radiation therapy for parotid mucoepidermoid carcinoma.

Salivary gland cancers are rare and represent approximately 5% of all head and neck cancers and only 0.3% of all malignancies. The majority (75%) of salivary gland tumors occur in the parotid gland, and while benign lesions are more common, mucoepidermoid carcinoma (MEC) makes up 40-50% of malignant parotid gland tumors.